...
search icon

Price related data not available

Gyre Therapeutics Inc. Analyst Forecast

Price related data not available

Gyre Therapeutics Inc. Stock Returns

Time FrameGYRESectorS&P500
1-Week Return4.59%0.72%-1.31%
1-Month Return3.53%1.27%0.78%
3-Month Return7.04%3.13%3.46%
6-Month Return4.59%15.81%6.19%
1-Year Return-35.35%8.89%11.68%
3-Year Return118.93%20.79%71.21%
5-Year Return-91.87%35.89%74.81%
10-Year Return-98.32%138.44%256.59%

Gyre Therapeutics Inc. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue20.95M7.34M102.29M113.45M105.76M[{"date":"2020-12-31","value":18.46,"profit":true},{"date":"2021-12-31","value":6.47,"profit":true},{"date":"2022-12-31","value":90.16,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":93.22,"profit":true}]
Cost of Revenue9.16M7.67M4.79M4.64M3.88M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":83.71,"profit":true},{"date":"2022-12-31","value":52.31,"profit":true},{"date":"2023-12-31","value":50.59,"profit":true},{"date":"2024-12-31","value":42.39,"profit":true}]
Gross Profit11.79M(332.00K)97.50M108.81M101.87M[{"date":"2020-12-31","value":10.83,"profit":true},{"date":"2021-12-31","value":-0.31,"profit":false},{"date":"2022-12-31","value":89.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":93.62,"profit":true}]
Gross Margin56.26%(4.52%)95.31%95.91%96.33%[{"date":"2020-12-31","value":58.4,"profit":true},{"date":"2021-12-31","value":-4.7,"profit":false},{"date":"2022-12-31","value":98.95,"profit":true},{"date":"2023-12-31","value":99.57,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses69.16M83.39M88.29M176.04M85.71M[{"date":"2020-12-31","value":39.28,"profit":true},{"date":"2021-12-31","value":47.37,"profit":true},{"date":"2022-12-31","value":50.15,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":48.69,"profit":true}]
Operating Income(57.37M)(83.73M)9.20M(67.23M)16.16M[{"date":"2020-12-31","value":-354.95,"profit":false},{"date":"2021-12-31","value":-518.01,"profit":false},{"date":"2022-12-31","value":56.94,"profit":true},{"date":"2023-12-31","value":-415.95,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense-(3.95M)935.00K(8.69M)8.60M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-45.89,"profit":false},{"date":"2022-12-31","value":10.87,"profit":true},{"date":"2023-12-31","value":-101.03,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(56.24M)(87.93M)9.41M(76.97M)23.22M[{"date":"2020-12-31","value":-242.23,"profit":false},{"date":"2021-12-31","value":-378.73,"profit":false},{"date":"2022-12-31","value":40.54,"profit":true},{"date":"2023-12-31","value":-331.49,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes(699.00K)(39.00K)5.10M8.52M5.32M[{"date":"2020-12-31","value":-8.21,"profit":false},{"date":"2021-12-31","value":-0.46,"profit":false},{"date":"2022-12-31","value":59.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":62.48,"profit":true}]
Income After Taxes-(87.89M)4.31M(85.48M)17.90M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-491.08,"profit":false},{"date":"2022-12-31","value":24.1,"profit":true},{"date":"2023-12-31","value":-477.6,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Continuous Operations-23.44M4.31M(85.48M)17.90M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":18.41,"profit":true},{"date":"2023-12-31","value":-364.73,"profit":false},{"date":"2024-12-31","value":76.37,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(55.54M)(87.93M)2.30M(92.93M)12.09M[{"date":"2020-12-31","value":-459.59,"profit":false},{"date":"2021-12-31","value":-727.62,"profit":false},{"date":"2022-12-31","value":19.05,"profit":true},{"date":"2023-12-31","value":-768.99,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)(42.45)(43.20)(3.75)(1.95)0.08[{"date":"2020-12-31","value":-54844.96,"profit":false},{"date":"2021-12-31","value":-55813.95,"profit":false},{"date":"2022-12-31","value":-4844.96,"profit":false},{"date":"2023-12-31","value":-2519.38,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Gyre Therapeutics Inc. Ratios

Gyre Therapeutics Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

GYRE
Cash Ratio 2.54
Current Ratio 6.19
Quick Ratio 5.64

Gyre Therapeutics Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

GYRE
ROA (LTM) 5.28%
ROE (LTM) 10.02%

Gyre Therapeutics Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

GYRE
Debt Ratio Lower is generally better. Negative is bad. 0.14
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.64

Gyre Therapeutics Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

GYRE
Trailing PE 205.25
Forward PE 80.00
P/S (TTM) 7.37
P/B 7.58
Price/FCF 198
EV/R 6.65
EV/Ebitda 49.70

FAQs

What is Gyre Therapeutics Inc. share price today?

Gyre Therapeutics Inc. (GYRE) share price today is $8.21

Can Indians buy Gyre Therapeutics Inc. shares?

Yes, Indians can buy shares of Gyre Therapeutics Inc. (GYRE) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GYRE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Gyre Therapeutics Inc. be purchased?

Yes, you can purchase fractional shares of Gyre Therapeutics Inc. (GYRE) via the Vested app. You can start investing in Gyre Therapeutics Inc. (GYRE) with a minimum investment of $1.

How to invest in Gyre Therapeutics Inc. shares from India?

You can invest in shares of Gyre Therapeutics Inc. (GYRE) via Vested in three simple steps:

  • Click on Sign Up or Invest in GYRE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Gyre Therapeutics Inc. shares
What is Gyre Therapeutics Inc. 52-week high and low stock price?

The 52-week high price of Gyre Therapeutics Inc. (GYRE) is $13.75. The 52-week low price of Gyre Therapeutics Inc. (GYRE) is $6.11.

What is Gyre Therapeutics Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Gyre Therapeutics Inc. (GYRE) is 205.25

What is Gyre Therapeutics Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Gyre Therapeutics Inc. (GYRE) is 7.58

What is Gyre Therapeutics Inc. dividend yield?

The dividend yield of Gyre Therapeutics Inc. (GYRE) is 0.00%

What is the Market Cap of Gyre Therapeutics Inc.?

The market capitalization of Gyre Therapeutics Inc. (GYRE) is $790.90M

What is Gyre Therapeutics Inc.'s stock symbol?

The stock symbol (or ticker) of Gyre Therapeutics Inc. is GYRE

How Can Investors Use Gyre Therapeutics Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Gyre Therapeutics Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Gyre Therapeutics Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Gyre Therapeutics Inc. shares for Indian investors?

When investing in Gyre Therapeutics Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Gyre Therapeutics Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Gyre Therapeutics Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of Gyre Therapeutics Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Gyre Therapeutics Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top